Scott Horner
Managing Director & Co-Founder @ Middleland Capital
Washington, United States
Scott Horner is a seed investor at Middleland Capital in Washington focused on Medical and Life Science. Scott is a Managing Director at Middleland Capital where he is responsible for portfolio management and evaluating investment opportunities in agriculture and biotechnology. Scott currently sits on the Board of Directors of Mycotechnology Inc., Plant Response Biotech, and Blue Prairie Brands, and is a Board observer on Advanced AnimalDiagnostics, Vive Crop Protection, ZeaKal, and Virgin Plants Inc. Prior to joining Middleland, Scott was a Managing Director at Third Security, LLC, where he was responsible for assessing potential investments in the biotechnology and pharmaceutical sectors. He also worked with many portfolio companies of Third Security’s managed investment funds providing business intelligence and operational support, and served on the Board of Directors of Synchrony Inc. (acquired by Dresser-Rand Corp.). In addition to portfolio management duties, he also took on interim operating roles within several portfolio companies, including President and Chief Executive Officer of Pinnacle Pharmaceuticals, VP Chemistry, Intrexon Corporation (NYSE:XON) and VP Business Development, Intrexon Corporation. Prior to joining Third Security, he was a founder and Chief Scientific Officer at Pathologics, LLC, a point of care diagnostics company located in Rochester, NY. Scott received his Ph.D. in Bioorganic Chemistry and an M.S. in Biophysics from the University of Rochester and a B.S. in Biochemistry from the State University of New York at Albany.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Scott Horner invests in
Stages Scott Horner invests in
Countries Scott Horner invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Medical 1 (100%)
- Life Science 1 (100%)
- Biotechnology 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Ordaōs is a human-enabled, machine-driven drug design company. We create customized mini-proteins that help pharma and biotechs around the world deliver safer and more effective life-saving treatments in a fraction of the time of traditional discovery methods. miniPRO proteins are created and evaluated in silico, and then rigorously tested invitro, which enables us to reliably and repeatedly deliver de novo solutions that meet our client’s stringent requirements at scale, including novelty and probability of clinical success. At Ordaōs, we help birth novel therapies that reduce patient suffering, improve health, and extend life. | $5M / Seed / Aug 25, 2022 |
Co-Investors
About Middleland Capital
Middleland Capital is a private investment firm focused on global early-stage technology opportunities. Leveraging a unique breadth of geographic and industry experience, the firm seeks partnerships with exceptional management teams to commercialize innovative technologies, accelerate growth, and build long-term value around the world.
Middleland Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Alexander Pessala
Investor
|
|||
|
David P. Mixer
Managing Partner
|
|||
|
Scott Horner
Managing Director & Co-Founder
|
|||
Severine Balick
Partner & Co-Founder
|
|||
|
Brian Mixer
Managing Director, Co-Founder & Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Scott Horner invest in?
Scott Horner invests primarily in Medical, Life Science and Biotechnology startups, most often at Seed stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Scott Horner?
Public channels for Scott Horner include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Scott Horner last invest?
The most recent investment recorded for Scott Horner closed in Aug 2022. Shizune tracks 1 investment in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
